On 7 and 8 June, ASAlaser welcomed 3 persons in charge of two well-known hospital centres in South Korea, accompanied by the staff of Asian Star, our local distributor, for a two-day training session. The two hospitals have been equipped with Hilterapia® devices for quite some time and represent important reference centres for the Korean care area market.
The first day was devoted to advanced level Hilterapia® training as the Korean doctors were already experienced in using the Hiro 3.0 system and an emphasis on customised procedures in order to obtain faster results was therefore required. The doctors were also very interested in the concept of “Specialized Pain Management Clinic”, i.e. in a Clinic specialising in pain management where patients are provided with optimal solutions for treating painful issues ranging from musculotendinous to joint pains, thanks to the combined use of Hilterapia®, MLS® Laser Therapy and Qs Magnetotherapy.
The first day was considered more than positive by everyone, and customers then had the opportunity of visiting two important medical centres equipped with Hilterapia® in order to inspect two different Italian companies. They witnessed treatments on actual patients at the Rehability Center, analysing the procedures learnt the first day and personally verifying how excellent results may be obtained in just a few minutes. The second visit to the Medical Physiotherapy Centre was planned in order to allow doctors to assimilate the all-round management of patients, from their registration to the end of the course of treatment, including ascertaining patients’ level of satisfaction.
At the end of the two-day training, the doctors stated they were satisfied with the knowledge gained and anxious to put the new treatment methods acquired into practice.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.